Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1(23)
  2. 10(9)
  3. 10C12(4)
  4. 10F.9G2(23)
  5. 116-13.1(10)
  6. 11B11(20)
  7. 12G5(5)
  8. 14-4-4S(10)
  9. 145-2C11(19)
  10. 15(9)
  11. 15-3-1S(4)
  12. 15A7(4)
  13. 16-10A1(19)
  14. 178 (LALAPG)(5)
  15. 17A2(8)
  16. 18B12(7)
  17. 1a3(5)
  18. 1A8(19)
  19. 1D11.1(5)
  20. 1D11.16.8(10)
  21. 1D3(14)
  22. 1F6(9)
  23. 1G9(26)
  24. 1H1(6)
  25. 2(23)
  26. 2.4G2(19)
  27. 20D5(14)
  28. 20H2(5)
  29. 225(4)
  30. 22D1(19)
  31. 24(5)
  32. 29E.2A3(16)
  33. 29F.1A12(19)
  34. 2D5(10)
  35. 2D5-1.9(9)
  36. 2H7(19)
  37. 3(28)
  38. 30-H12(19)
  39. 33D1(40)
  40. 37(9)
  41. 38(5)
  42. 38/42(4)
  43. 384-35(5)
  44. 3E8#(4)
  45. 3G8(15)
  46. 3H10.1(19)
  47. 3H3(19)
  48. 4(5)
  49. 43(9)
  50. 480(14)
  51. 4A9(18)
  52. 4E1.2(9)
  53. 4LO3311(18)
  54. 50-6(5)
  55. 500A2(20)
  56. 509F6(8)
  57. 51(9)
  58. 53-5.8(19)
  59. 53-6.7(19)
  60. 55R-170(15)
  61. 55R-593(15)
  62. 5C8(3)
  63. 5G11(11)
  64. 6B11(5)
  65. 7B10(15)
  66. 7E.17G9(19)
  67. 7G7B6(19)
  68. 8C8(9)
  69. 9(5)
  70. 9000000000(10)
  71. 927(18)
  72. 9a2(9)
  73. 9D9(19)
  74. 9E9(8)
  75. 9H10(23)
  76. A4C8.1-Do9(10)
  77. A7R34(6)
  78. Abituzumab(3)
  79. Abrilumab(3)
  80. Aducanumab(3)
  81. AF6-88.5(9)
  82. Afasevikumab(3)
  83. AFS98(19)
  84. ALF-161(10)
  85. Amatuximab(3)
  86. Anifrolumab(3)
  87. Anrukinzumab(3)
  88. Apamistamab(3)
  89. Aprutumab(3)
  90. Atezolizumab(3)
  91. Atibuclimab(3)
  92. Avelumab(3)
  93. Avizakimab(3)
  94. B122(10)
  95. B22/249(14)
  96. B6H12(21)
  97. B7/21(5)
  98. B8-24-3(14)
  99. B8.2C12(5)
  100. Bamlanivimab(3)
  101. Bapineuzumab(3)
  102. Basiliximab(3)
  103. Batoclimab(3)
  104. Bavbio(5)
  105. Bavituximab(3)
  106. BC8(19)
  107. BE29G1(15)
  108. Begelomab(3)
  109. Belantamab(3)
  110. Belimumab(3)
  111. Bemarituzumab(3)
  112. Bermekimab(3)
  113. Bersanlimab(3)
  114. Bertilimumab(3)
  115. Bevacizumab(3)
  116. Bexmarilimab(3)
  117. Bimekizumab(3)
  118. Bivatuzumab(3)
  119. Bleselumab(3)
  120. Blosozumab(3)
  121. Bococizumab(3)
  122. Brazikumab(3)
  123. Brentuximab(3)
  124. Briakinumab(3)
  125. Brodalumab(3)
  126. Burosumab(3)
  127. BVD6-24G2(4)
  128. C1.18.4(11)
  129. C17.8(7)
  130. C71/16(16)
  131. C9B7W(18)
  132. Cadbio(5)
  133. Camidanlumab(3)
  134. Camrelizumab(3)
  135. Canakinumab(3)
  136. Caplacizumab(7)
  137. Carlumab(3)
  138. CD28.2(7)
  139. Cedelizumab(3)
  140. Cemiplimab(3)
  141. Cendakimab(3)
  142. Cetuximab(3)
  143. CHK-166(10)
  144. CHK152(5)
  145. Cibbio(5)
  146. Cixutumumab(3)
  147. Clazakizumab(3)
  148. Clenoliximab(3)
  149. Clervonafusp Alfa(4)
  150. Clesrovimab(3)
  151. Codrituzumab(3)
  152. Coltuximab(3)
  153. Cusatuzumab(3)
  154. CXCR3-173(18)
  155. Cy34.1(22)
  156. D12(4)
  157. D5(10)
  158. Dacetuzumab(3)
  159. Daclizumab(3)
  160. Daratumumab(3)
  161. DATK32(15)
  162. Daxdilimab(3)
  163. DC101(14)
  164. Dectrekumab(3)
  165. Denintuzumab(3)
  166. Denosumab(3)
  167. DREG56(5)
  168. Dupilumab(3)
  169. Durvalumab(3)
  170. Dusigitumab(3)
  171. E18(10)
  172. Edrecolomab(3)
  173. Efalizumab(3)
  174. EGFR.1(14)
  175. Eldelumab(3)
  176. Elipovimab(3)
  177. Elotuzumab(3)
  178. Emapalumab(3)
  179. Emibetuzumab(3)
  180. Enfortumab(3)
  181. Enibarcimab(3)
  182. Enoblituzumab(3)
  183. Enokizumab(3)
  184. Epratuzumab(5)
  185. Eptinezumab(3)
  186. Erenumab(3)
  187. ERIC-1(11)
  188. Erlizumab(3)
  189. Etaracizumab(3)
  190. Etokimab(3)
  191. Etrolizumab(3)
  192. Evinacumab(3)
  193. Evolocumab(3)
  194. Faralimomab(3)
  195. Farletuzumab(3)
  196. Fasinumab(3)
  197. FD441.8(15)
  198. Felzartamab(3)
  199. Fezakinumab(3)
  200. FGK4.5(19)
  201. FIB21(9)
  202. FIB27(3)
  203. FIB504(24)
  204. Ficlatuzumab(3)
  205. Figitumumab(3)
  206. Fletikumab(3)
  207. Fontolizumab(3)
  208. Foralumab(3)
  209. FR70(11)
  210. Fremanezumab(3)
  211. Fresolimumab(3)
  212. Frunevetmab(3)
  213. Fulranumab(3)
  214. G11(5)
  215. G28.5(19)
  216. G8.8(14)
  217. Galcanezumab(3)
  218. Gantenerumab(3)
  219. Gatralimab(3)
  220. Gemtuzumab(3)
  221. Gevokizumab(3)
  222. Giloralimab(3)
  223. Gimsilumab(3)
  224. GIR 208(9)
  225. Girentuximab(3)
  226. GK1.5(19)
  227. GL1(14)
  228. GL113(3)
  229. Glembatumumab(3)
  230. Grebio(5)
  231. Guselkumab(3)
  232. H22(20)
  233. H57-597(14)
  234. HB-14(7)
  235. HDB-4A7(9)
  236. HEK/1/85a/7a(18)
  237. HK1.4(10)
  238. HK2.1(15)
  239. HK5.3(15)
  240. HKSP(10)
  241. HKSP84(10)
  242. HM48-1(17)
  243. I21/7(15)
  244. I3/2.3(10)
  245. Ibalizumab(3)
  246. ICRF44(5)
  247. Ieramilimab(3)
  248. Ifibio(5)
  249. Ifinatamab(3)
  250. IK22/5(9)
  251. IM7(19)
  252. Indusatumab(3)
  253. Infliximab(3)
  254. Inolimomab(3)
  255. Intetumumab(3)
  256. Ipilimumab(3)
  257. Iratumumab(3)
  258. Isatuximab(3)
  259. Iscalimab(3)
  260. Itepekimab(3)
  261. Itolizumab(3)
  262. Ivuxolimab(3)
  263. Ixekizumab(3)
  264. J43(4)
  265. JAMA-147(10)
  266. JES5-2A5(4)
  267. JES6-1A12(5)
  268. JES6-5H4(4)
  269. Keliximab(3)
  270. L243(10)
  271. Lacnotuzumab(3)
  272. Lebrikizumab(3)
  273. Lemzoparlimab(3)
  274. Lenzilumab(3)
  275. Lerdelimumab(3)
  276. Lintuzumab(3)
  277. LO-CD2a(4)
  278. Lucatumumab(3)
  279. Lulizumab(3)
  280. Lumiliximab(3)
  281. Lusvertikimab(3)
  282. M1/69(8)
  283. M1/70(15)
  284. M290(4)
  285. M5/114.15.2(18)
  286. M5/49.4.1(10)
  287. Magrolimab(3)
  288. MAR 18.5(18)
  289. MAR1-5A3(19)
  290. Margetuximab(3)
  291. Matuzumab(3)
  292. Mavrilimumab(3)
  293. MB22-11(14)
  294. MD5-1(15)
  295. MECA-367(14)
  296. MECA-89(10)
  297. MEL-14(15)
  298. Metelimumab(3)
  299. Mezagitamab(3)
  300. MFL3(18)
  301. MIB-5E9.1(5)
  302. MIG-2F5-5(18)
  303. Minretumomab(3)
  304. Mirikizumab(3)
  305. Mirvetuximab(3)
  306. Mitazalimab(3)
  307. MJ18(18)
  308. MJ7/18(8)
  309. Monalizumab(3)
  310. Motavizumab(3)
  311. MP1-22E9(19)
  312. MP4-25D2(7)
  313. MP5-20F3(4)
  314. MPC-11(10)
  315. MR1(4)
  316. Mupadolimab(3)
  317. Muromonab(3)
  318. N418(5)
  319. Nadunolimab(3)
  320. Namilumab(3)
  321. Naratuximab(3)
  322. Natalizumab(3)
  323. Naxitamab(3)
  324. Necitumumab(3)
  325. Nemolizumab(3)
  326. Nerelimomab(3)
  327. Nesvacumab(3)
  328. Netakimab(3)
  329. Nipocalimab(3)
  330. Nivolumab(3)
  331. Obexelimab(3)
  332. Ocaratuzumab(3)
  333. Odulimomab(3)
  334. Ofatumumab(3)
  335. OKT-4(19)
  336. OKT10(19)
  337. Oleclumab(3)
  338. Olokizumab(3)
  339. Omalizumab(3)
  340. Omburtamab(3)
  341. Onvatilimab(3)
  342. Otelixizumab(3)
  343. Otilimab(3)
  344. OX-26(18)
  345. OX-7(18)
  346. OX-86(19)
  347. OX-90(18)
  348. Ozanezumab(3)
  349. Ozuriftamab(3)
  350. P84(9)
  351. Palivizumab(3)
  352. Pamrevlumab(3)
  353. Panitumumab(3)
  354. Parsatuzumab(3)
  355. Pascolizumab(3)
  356. Patbio(5)
  357. Pateclizumab(3)
  358. Patritumab(3)
  359. PC61(14)
  360. Pembrolizumab(3)
  361. Penpulimab(3)
  362. Perakizumab(3)
  363. Pertuzumab(3)
  364. Pinatuzumab(3)
  365. Pivekimab(3)
  366. PK136(19)
  367. Polatuzumab(3)
  368. Ponezumab(3)
  369. Ponsegromab(3)
  370. PS/2(18)
  371. Quetmolimab(3)
  372. R1-2(3)
  373. R4-6A2(12)
  374. RA3-6B2(19)
  375. Ramucirumab(3)
  376. Ravagalimab(3)
  377. RB6-8C5(19)
  378. Relatlimab(3)
  379. RG9-1(18)
  380. Rilotumumab(3)
  381. Ripertamab(3)
  382. Rituximab(5)
  383. RM134L(14)
  384. RM27-3E5(23)
  385. RMP1-14(26)
  386. RMP1-14-mAbMods(5)
  387. RMP1-14-mAbMods (D265A)(5)
  388. RMP1-14-mAbMods (LALA-PG)(5)
  389. RMP1-30(6)
  390. RMT1-10(14)
  391. RMT3-23(10)
  392. RMT4-53(10)
  393. Robatumumab(3)
  394. Rolinsatamab(3)
  395. Romosozumab(3)
  396. Rontalizumab(3)
  397. Rosopatamab(3)
  398. Rovalpituzumab(3)
  399. Rozanolixizumab(3)
  400. Sabatolimab(3)
  401. Sacituzumab(3)
  402. Sarilumab(3)
  403. Satralizumab(3)
  404. Secukinumab(3)
  405. Selicrelumab(3)
  406. Sifalimumab(3)
  407. Siltuximab(3)
  408. Simtuzumab(3)
  409. Sintilimab(3)
  410. Siplizumab(3)
  411. Sirukumab(3)
  412. SJ25-C1(6)
  413. Sofituzumab(3)
  414. Sotigalimab(3)
  415. Spesolimab(3)
  416. Sutimlimab(3)
  417. Suvizumab(3)
  418. T24/31(19)
  419. T29/33(5)
  420. T3-3A1(5)
  421. T56/14(5)
  422. TA-99(10)
  423. Tabalumab(3)
  424. Tadocizumab(3)
  425. Tafasitamab(3)
  426. Talbio(5)
  427. TAN1-7(19)
  428. Tanezumab(3)
  429. Tecbio(5)
  430. Teneliximab(3)
  431. Teplizumab(3)
  432. Teprotumumab(3)
  433. Tezepelumab(3)
  434. TIF-3C5(9)
  435. Tilavonemab(3)
  436. Tilvestamab(3)
  437. Tinurilimab(3)
  438. Tiragolumab(3)
  439. Tislelizumab(3)
  440. TKS-1(18)
  441. TN3-19.12(19)
  442. Tocilizumab(3)
  443. Toripalimab(3)
  444. Tositumomab(3)
  445. Tovetumab(3)
  446. TR75-54.7(15)
  447. Tralokinumab(3)
  448. Trastuzumab(3)
  449. Tregalizumab(3)
  450. TRFK5(14)
  451. Tusamitamab(3)
  452. TY/23(25)
  453. TY25(9)
  454. Ublituximab(3)
  455. UC10-4F10-11(19)
  456. UC3-10A6(15)
  457. UC7-13D5(10)
  458. UCHL-1(5)
  459. UCHM-1(5)
  460. UCHT-1(10)
  461. UCHT-2(5)
  462. UCHT-4(5)
  463. Uliledlimab(3)
  464. Upifitamab(3)
  465. Urabrelimab(3)
  466. Urelumab(3)
  467. Ustekinumab(3)
  468. Utomilumab(3)
  469. Vadastuximab(3)
  470. Vanalimab(3)
  471. Varisacumab(3)
  472. Varlilumab(3)
  473. Vatelizumab(3)
  474. Vedolizumab(3)
  475. Veltuzumab(3)
  476. Vibostolimab(3)
  477. Visilizumab(3)
  478. VL-4(10)
  479. Volociximab(3)
  480. Vunakizumab(3)
  481. W6/32(15)
  482. Xentuzumab(3)
  483. XMG1.2(19)
  484. Y-3(15)
  485. Y-3P(10)
  486. YN1/1.7.4(19)
  487. YTS-169(19)
  488. YTS191(18)
  489. Zagotenemab(3)
  490. Zalutumumab(3)
  491. Zanolimumab(3)
  492. Zilovertamab(3)
  493. Ziltivekimab(3)
  494. Zinlirvimab(3)
  495. Zolbetuximab(3)
  496. Zolimomab(3)
  497. ZV67(5)
Applications
Isotype
Hersteller

In Vivo Antibodies

13369 Artikel

pro Seite

Seite:
  1. 68
  2. 69
  3. 70
  4. 71
  5. 72
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Anti-­Mouse CD309 (DC101) In Vivo Antibody -­ Low Endotoxin Antibody Monoclonal DC101 Mu WB, FA Rat ICH1232-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Anti-­Mouse integrin β7 (FIB21) In Vivo Antibody -­ Low Endotoxin Antibody Monoclonal FIB21 Hu, Mu FC, Blocking, IV Rat ICH1234-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Anti-­Mouse integrin β7 (FIB21) In Vivo Antibody -­ Low Endotoxin Antibody Monoclonal FIB21 Hu, Mu FC, Blocking, IV Rat ICH1234-25mg

IchorBio 		25 mg Anmelden
Vergleichen
Anti-­Mouse integrin β7 (FIB21) In Vivo Antibody -­ Low Endotoxin Antibody Monoclonal FIB21 Hu, Mu FC, Blocking, IV Rat ICH1234-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Anti-­Mouse integrin β7 (FIB21) In Vivo Antibody -­ Low Endotoxin Antibody Monoclonal FIB21 Hu, Mu FC, Blocking, IV Rat ICH1234-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Anti-­Mouse MHC Class I H-­2Kk, H-­2Dk (15-­3-­1S) In Vivo Antibody -­ Low Endotoxin Antibody Monoclonal 15-3-1S Mu FC, IF, Blocking, FA Mouse ICH1235-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Anti-­Mouse MHC Class I H-­2Kk, H-­2Dk (15-­3-­1S) In Vivo Antibody -­ Low Endotoxin Antibody Monoclonal 15-3-1S Mu FC, IF, Blocking, FA Mouse ICH1235-25mg

IchorBio 		25 mg Anmelden
Vergleichen
Anti-­Mouse MHC Class I H-­2Kk, H-­2Dk (15-­3-­1S) In Vivo Antibody -­ Low Endotoxin Antibody Monoclonal 15-3-1S Mu FC, IF, Blocking, FA Mouse ICH1235-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Anti-­Mouse MHC Class I H-­2Kk, H-­2Dk (15-­3-­1S) In Vivo Antibody -­ Low Endotoxin Antibody Monoclonal 15-3-1S Mu FC, IF, Blocking, FA Mouse ICH1235-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Anti-­Mouse DR5 (MD5-­1) In Vivo Antibody -­ Low Endotoxin Antibody Monoclonal MD5-1 Mu WB, FC, IP, FA Hamster - Armenian ICH1236-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Anti-­Mouse DR5 (MD5-­1) In Vivo Antibody -­ Low Endotoxin Antibody Monoclonal MD5-1 Mu WB, FC, IP, FA Hamster - Armenian ICH1236-25mg

IchorBio 		25 mg Anmelden
Vergleichen
Anti-­Mouse DR5 (MD5-­1) In Vivo Antibody -­ Low Endotoxin Antibody Monoclonal MD5-1 Mu WB, FC, IP, FA Hamster - Armenian ICH1236-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Anti-­Mouse DR5 (MD5-­1) In Vivo Antibody -­ Low Endotoxin Antibody Monoclonal MD5-1 Mu WB, FC, IP, FA Hamster - Armenian ICH1236-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Epratuzumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5194-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Epratuzumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5194-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Epratuzumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5194-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Epratuzumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5194-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Epratuzumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5194-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Galiximab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5196-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Galiximab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5196-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Galiximab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5196-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Galiximab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5196-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Galiximab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5196-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Galiximab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5196-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Casirivimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5200-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Name Preis
Anti-­Mouse CD309 (DC101) In Vivo Antibody -­ Low Endotoxin Anmelden Anti-Mouse CD309 (DC101) In Vivo Antibody - Low Endotoxin
Typ Antibody Monoclonal
Clone DC101
Specific against Mu
Appl. WB, FA
Host Rat
ArtNr.
Menge 5 mg
Lieferbar
Anti-­Mouse integrin β7 (FIB21) In Vivo Antibody -­ Low Endotoxin Anmelden Anti-Mouse integrin β7 (FIB21) In Vivo Antibody - Low Endotoxin
Typ Antibody Monoclonal
Clone FIB21
Specific against Hu, Mu
Appl. FC, Blocking, IV
Host Rat
ArtNr.
Menge 100 mg
Lieferbar
Anti-­Mouse integrin β7 (FIB21) In Vivo Antibody -­ Low Endotoxin Anmelden Anti-Mouse integrin β7 (FIB21) In Vivo Antibody - Low Endotoxin
Typ Antibody Monoclonal
Clone FIB21
Specific against Hu, Mu
Appl. FC, Blocking, IV
Host Rat
ArtNr.
Menge 25 mg
Lieferbar
Anti-­Mouse integrin β7 (FIB21) In Vivo Antibody -­ Low Endotoxin Anmelden Anti-Mouse integrin β7 (FIB21) In Vivo Antibody - Low Endotoxin
Typ Antibody Monoclonal
Clone FIB21
Specific against Hu, Mu
Appl. FC, Blocking, IV
Host Rat
ArtNr.
Menge 50 mg
Lieferbar
Anti-­Mouse integrin β7 (FIB21) In Vivo Antibody -­ Low Endotoxin Anmelden Anti-Mouse integrin β7 (FIB21) In Vivo Antibody - Low Endotoxin
Typ Antibody Monoclonal
Clone FIB21
Specific against Hu, Mu
Appl. FC, Blocking, IV
Host Rat
ArtNr.
Menge 5 mg
Lieferbar
Anti-­Mouse MHC Class I H-­2Kk, H-­2Dk (15-­3-­1S) In Vivo Antibody -­ Low Endotoxin Anmelden Anti-Mouse MHC Class I H-2Kk, H-2Dk (15-3-1S) In Vivo Antibody - Low Endotoxin
Typ Antibody Monoclonal
Clone 15-3-1S
Specific against Mu
Appl. FC, IF, Blocking, FA
Host Mouse
ArtNr.
Menge 100 mg
Lieferbar
Anti-­Mouse MHC Class I H-­2Kk, H-­2Dk (15-­3-­1S) In Vivo Antibody -­ Low Endotoxin Anmelden Anti-Mouse MHC Class I H-2Kk, H-2Dk (15-3-1S) In Vivo Antibody - Low Endotoxin
Typ Antibody Monoclonal
Clone 15-3-1S
Specific against Mu
Appl. FC, IF, Blocking, FA
Host Mouse
ArtNr.
Menge 25 mg
Lieferbar
Anti-­Mouse MHC Class I H-­2Kk, H-­2Dk (15-­3-­1S) In Vivo Antibody -­ Low Endotoxin Anmelden Anti-Mouse MHC Class I H-2Kk, H-2Dk (15-3-1S) In Vivo Antibody - Low Endotoxin
Typ Antibody Monoclonal
Clone 15-3-1S
Specific against Mu
Appl. FC, IF, Blocking, FA
Host Mouse
ArtNr.
Menge 50 mg
Lieferbar
Anti-­Mouse MHC Class I H-­2Kk, H-­2Dk (15-­3-­1S) In Vivo Antibody -­ Low Endotoxin Anmelden Anti-Mouse MHC Class I H-2Kk, H-2Dk (15-3-1S) In Vivo Antibody - Low Endotoxin
Typ Antibody Monoclonal
Clone 15-3-1S
Specific against Mu
Appl. FC, IF, Blocking, FA
Host Mouse
ArtNr.
Menge 5 mg
Lieferbar
Anti-­Mouse DR5 (MD5-­1) In Vivo Antibody -­ Low Endotoxin Anmelden Anti-Mouse DR5 (MD5-1) In Vivo Antibody - Low Endotoxin
Typ Antibody Monoclonal
Clone MD5-1
Specific against Mu
Appl. WB, FC, IP, FA
Host Hamster - Armenian
ArtNr.
Menge 100 mg
Lieferbar
Anti-­Mouse DR5 (MD5-­1) In Vivo Antibody -­ Low Endotoxin Anmelden Anti-Mouse DR5 (MD5-1) In Vivo Antibody - Low Endotoxin
Typ Antibody Monoclonal
Clone MD5-1
Specific against Mu
Appl. WB, FC, IP, FA
Host Hamster - Armenian
ArtNr.
Menge 25 mg
Lieferbar
Anti-­Mouse DR5 (MD5-­1) In Vivo Antibody -­ Low Endotoxin Anmelden Anti-Mouse DR5 (MD5-1) In Vivo Antibody - Low Endotoxin
Typ Antibody Monoclonal
Clone MD5-1
Specific against Mu
Appl. WB, FC, IP, FA
Host Hamster - Armenian
ArtNr.
Menge 50 mg
Lieferbar
Anti-­Mouse DR5 (MD5-­1) In Vivo Antibody -­ Low Endotoxin Anmelden Anti-Mouse DR5 (MD5-1) In Vivo Antibody - Low Endotoxin
Typ Antibody Monoclonal
Clone MD5-1
Specific against Mu
Appl. WB, FC, IP, FA
Host Hamster - Armenian
ArtNr.
Menge 5 mg
Lieferbar
Epratuzumab Biosimilar -­ Research Grade Anmelden Epratuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Epratuzumab Biosimilar -­ Research Grade Anmelden Epratuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Epratuzumab Biosimilar -­ Research Grade Anmelden Epratuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 10 mg
Lieferbar
Epratuzumab Biosimilar -­ Research Grade Anmelden Epratuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 20 mg
Lieferbar
Epratuzumab Biosimilar -­ Research Grade Anmelden Epratuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Galiximab Biosimilar -­ Research Grade Anmelden Galiximab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Galiximab Biosimilar -­ Research Grade Anmelden Galiximab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Galiximab Biosimilar -­ Research Grade Anmelden Galiximab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 10 mg
Lieferbar
Galiximab Biosimilar -­ Research Grade Anmelden Galiximab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 20 mg
Lieferbar
Galiximab Biosimilar -­ Research Grade Anmelden Galiximab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Galiximab Biosimilar -­ Research Grade Anmelden Galiximab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 100 mg
Lieferbar
Casirivimab Biosimilar -­ Research Grade Anmelden Casirivimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar

13369 Artikel

pro Seite

Seite:
  1. 68
  2. 69
  3. 70
  4. 71
  5. 72
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top